CN Patent

CN101605569B — 注射按钮

Assigned to Novo Nordisk AS · Expires 2012-09-05 · 14y expired

What this patent protects

一种用于注射设备的按钮连接，包括按钮(10)和驱动部件(20)。按钮连接的上述两个部件彼此组装在一起，并且能够相对转动。为了减小在按钮和驱动部件相对转动时产生的摩擦力，力通过枢轴轴承(18，22)被传递。也为了减小偏离中心线的力造成的影响，设置多个具有小摩擦直径的径向轴承(13，23；14，25)。

USPTO Abstract

一种用于注射设备的按钮连接，包括按钮(10)和驱动部件(20)。按钮连接的上述两个部件彼此组装在一起，并且能够相对转动。为了减小在按钮和驱动部件相对转动时产生的摩擦力，力通过枢轴轴承(18，22)被传递。也为了减小偏离中心线的力造成的影响，设置多个具有小摩擦直径的径向轴承(13，23；14，25)。

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: CN101605569B
Jurisdiction: CN
Classification: —
Expires: 2012-09-05
Drug substance claim: No
Drug product claim: No
Assignee: Novo Nordisk AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.